Lifeward (LFWD) Return on Capital Employed (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,537.00 |
| Dec 31, 2025 | 816.00 |
| Sep 30, 2025 | -1,605.00 |
| Jun 30, 2025 | -3,644.00 |
| Mar 31, 2025 | -2,943.00 |
| Dec 31, 2024 | -5,286.00 |
| Sep 30, 2024 | 570.00 |
| Jun 30, 2024 | -561.00 |
| Mar 31, 2024 | -901.00 |
| Dec 31, 2023 | -230.00 |
| Sep 30, 2023 | -886.00 |
| Jun 30, 2023 | -390.00 |
| Mar 31, 2023 | -207.00 |
| Dec 31, 2022 | -359.00 |
| Sep 30, 2022 | -465.00 |
| Jun 30, 2022 | -234.00 |
| Mar 31, 2022 | -203.00 |
| Dec 31, 2021 | 71.00 |
| Sep 30, 2021 | 307.00 |
| Jun 30, 2021 | 673.00 |
| Mar 31, 2021 | 2,924.00 |
| Dec 31, 2020 | 2,049.00 |
| Sep 30, 2020 | 811.00 |
| Jun 30, 2020 | 1,546.00 |
| Mar 31, 2020 | -1,090.00 |
| Dec 31, 2019 | -8,372.00 |
| Sep 30, 2019 | 757.00 |
| Jun 30, 2019 | 2,075.00 |
| Mar 31, 2019 | 3,089.00 |
| Dec 31, 2018 | 55,136.00 |
| Sep 30, 2018 | -26,289.00 |
| Jun 30, 2018 | -11,692.00 |
| Mar 31, 2018 | -5,691.00 |
| Dec 31, 2017 | 703.00 |
| Sep 30, 2017 | 2,005.00 |
| Jun 30, 2017 | -1,453.00 |
| Mar 31, 2017 | 2,986.00 |
| Dec 31, 2016 | 2,541.00 |
| Sep 30, 2016 | -8,475.00 |
| Jun 30, 2016 | -3,586.00 |
| Mar 31, 2016 | -2,293.00 |